Repurposing Hydroxychloroquine as a Model Drug for the Prediction of Potential SARS-CoV-2 Inhibitor

##plugins.themes.bootstrap3.article.main##

  •   K. K. Igwe

  •   O. V. Ikpeazu

  •   F. J. Amaku

  •   I. E. Otuokere

Abstract

The use of hydroxychloroquine as SARS-CoV-2 inhibitor is currently being reviewed in various clinical trials.  To exhaustively assess the benefit of hydroxychloroquine in the search for SARS-CoV-2 cure, this paper repositioned hydroxychloroquine as a model for virtual screening on the ZINC database.  Molecular docking studies of 5r7y with the retrieved molecules were performed.  The S-score of the predicted compounds were compared with the reference inhibitor (hydroxychloroquine).  After evaluating their binding energy, five compounds (ZINC52939663, ZINC21291670, ZINC12714071, ZINC40089978 and ZINC15963294) were noticed have to highest binding energy with SARS-CoV-2.  The binding scores of the top five ligands were higher than that of the reference molecule.  The pharmacokinetics, toxicity prediction, drug-likeness and global reactivity assessment of ZINC52939663, present the lead compound as a drug candidate with the probable capacity to inhibit SARS-CoV-2.


Keywords: SARS-CoV-2, Virtual Screening, Hydroxychloroquine, Molecular Docking

References

Zhou, Y., et al., Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell discovery, 2020. 6(1): p. 1-18.

Zhou, D., S.-M. Dai, and Q. Tong, COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Journal of Antimicrobial Chemotherapy, 2020.

Vardhan, S. and S.K. Sahoo, Searching inhibitors for three important proteins of COVID-19 through molecular docking studies. arXiv preprint arXiv:2004.08095, 2020.

Enmozhi, S.K., et al., Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics, 2020: p. 1-7.

Amin, M. and G. Abbas, Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs. Journal of Biomolecular Structure and Dynamics, 2020(just-accepted): p. 1-11.

Wang, X., et al., SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cellular & Molecular Immunology, 2020: p. 1-3.

Sarkar, S.K., COVID-19 Susceptibility Mapping Using Multicriteria Evaluation. Disaster Medicine and Public Health Preparedness: p. 1-17.

Rainsford, K., et al., Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology, 2015. 23(5): p. 231-269.

Al-Bari, M.A.A., Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. Journal of Antimicrobial Chemotherapy, 2015. 70(6): p. 1608-1621.

Haka, A.S., et al., In vivo margin assessment during partial mastectomy breast surgery using Raman spectroscopy. Cancer research, 2006. 66(6): p. 3317-3322.

Mizui, T., et al., Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. Journal of gastroenterology, 2010. 45(2): p. 195-203.

Delvecchio, R., et al., Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models. Viruses, 2016. 8(12): p. 322.

Dowall, S.D., et al., Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model. The Journal of general virology, 2015. 96(Pt 12): p. 3484.

Kouroumalis, E. and J. Koskinas, Treatment of chronic active hepatitis B (CAH B) with chloroquine: a preliminary report. Annals of the Academy of Medicine, Singapore, 1986. 15(2): p. 149-152.

Morris, G.M., et al., Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of computational chemistry, 1998. 19(14): p. 1639-1662.

Pettersen, E.F., et al., UCSF Chimera—a visualization system for exploratory research and analysis. Journal of computational chemistry, 2004. 25(13): p. 1605-1612.

Koes, D.R. and C.J. Camacho, ZINCPharmer: pharmacophore search of the ZINC database. Nucleic acids research, 2012. 40(W1): p. W409-W414.

Hanwell, M.D., et al., Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Journal of cheminformatics, 2012. 4(1): p. 17.

Monteiro, A., M. Scotti, and L. Scotti. Molecular docking of fructose-derived nucleoside analogs against reverse transcriptase of HIV-1. in Proceedings of MOL2NET 2019, International Conference on Multidisciplinary Sciences, 5th edition. 2019. MDPI.

Gaussian09, R.A., M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Gonzalez, J.A. Pople, Gaussian 09, Revision E.01, Gaussian, Inc, Wallingford, CT, 2004. Inc., Wallingford CT, 2009. 121: p. 150-166.

Becke, A.D., Real-space post-Hartree–Fock correlation models. The Journal of chemical physics, 2005. 122(6): p. 064101.

Koopmans, T., Über die Zuordnung von Wellenfunktionen und Eigenwerten zu den einzelnen Elektronen eines Atoms. Physica, 1934. 1(1-6): p. 104-113.

Ayers, P.W. and M. Levy, Perspective on “Density functional approach to the frontier-electron theory of chemical reactivity”. Theoretical Chemistry Accounts, 2000. 103(3-4): p. 353-360.

Chermette, H., Chemical reactivity indexes in density functional theory. Journal of Computational Chemistry, 1999. 20(1): p. 129-154.

Geerlings, P., F. De Proft, and W. Langenaeker, Conceptual density functional theory. Chemical reviews, 2003. 103(5): p. 1793-1874.

Gazquez, J.L., A. Cedillo, and A. Vela, Electrodonating and electroaccepting powers. The Journal of Physical Chemistry A, 2007. 111(10): p. 1966-1970.

Chattaraj, P.K., A. Chakraborty, and S. Giri, Net electrophilicity. The Journal of Physical Chemistry A, 2009. 113(37): p. 10068-10074.

Sahoo, M., S.D. Lingaraja Jena, and S. Kumar, Virtual screening for potential inhibitors of NS3 protein of Zika virus. Genomics & informatics, 2016. 14(3): p. 104.

Abdullahi, M., F.A. Olotu, and M.E. Soliman, Allosteric inhibition abrogates dysregulated LFA-1 activation: Structural insight into mechanisms of diminished immunologic disease. Computational biology and chemistry, 2018. 73: p. 49-56.

Patil, R., et al., Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PloS one, 2010. 5(8).

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
[1]
Igwe, K., Ikpeazu, O., Amaku, F. and Otuokere, I. 2020. Repurposing Hydroxychloroquine as a Model Drug for the Prediction of Potential SARS-CoV-2 Inhibitor. European Journal of Engineering Research and Science. 5, 9 (Sep. 2020), 1031-1036. DOI:https://doi.org/10.24018/ejers.2020.5.9.2056.